ethyl 4-hydroxy-2-methylquinoline-3-carboxylate

ID: ALA214415

Cas Number: 7521-63-3

PubChem CID: 2986317

Max Phase: Preclinical

Molecular Formula: C13H13NO3

Molecular Weight: 231.25

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCOC(=O)c1c(C)nc2ccccc2c1O

Standard InChI:  InChI=1S/C13H13NO3/c1-3-17-13(16)11-8(2)14-10-7-5-4-6-9(10)12(11)15/h4-7H,3H2,1-2H3,(H,14,15)

Standard InChI Key:  PHRRSYMXOIKRAW-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 17 18  0  0  0  0  0  0  0  0999 V2000
   -5.7602    2.0043    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7613    1.1769    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0465    0.7641    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0483    2.4172    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3328    2.0079    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3321    1.1811    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6168    0.7701    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9016    1.1849    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9064    2.0149    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6224    2.4222    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6268    3.2472    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1945    2.4318    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4774    2.0237    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1995    3.2568    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7654    2.4405    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0484    2.0324    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1856    0.7752    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  5  4  2  0
  8  9  1  0
  4  1  1  0
  9 10  2  0
 10  5  1  0
 10 11  1  0
  2  3  1  0
  9 12  1  0
  5  6  1  0
 12 13  1  0
  3  6  2  0
 12 14  2  0
  6  7  1  0
 13 15  1  0
  1  2  2  0
 15 16  1  0
  7  8  2  0
  8 17  1  0
M  END

Associated Targets(Human)

EP300 Tchem Histone acetyltransferase p300 (1259 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CREBBP Tchem CREB-binding protein (1602 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KAT2A Tchem Histone acetyltransferase GCN5 (14285 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KAT2B Tchem Histone acetyltransferase PCAF (884 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
U-937 (7138 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

GCN5 Histone acetyltransferase GCN5 (89 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 231.25Molecular Weight (Monoisotopic): 231.0895AlogP: 2.43#Rotatable Bonds: 2
Polar Surface Area: 59.42Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 10.65CX Basic pKa: 2.24CX LogP: 2.97CX LogD: 2.97
Aromatic Rings: 2Heavy Atoms: 17QED Weighted: 0.81Np Likeness Score: -0.59

References

1. Mai A, Rotili D, Tarantino D, Ornaghi P, Tosi F, Vicidomini C, Sbardella G, Nebbioso A, Miceli M, Altucci L, Filetici P..  (2006)  Small-molecule inhibitors of histone acetyltransferase activity: identification and biological properties.,  49  (23): [PMID:17154519] [10.1021/jm060601m]
2. Mai A, Rotili D, Tarantino D, Nebbioso A, Castellano S, Sbardella G, Tini M, Altucci L..  (2009)  Identification of 4-hydroxyquinolines inhibitors of p300/CBP histone acetyltransferases.,  19  (4): [PMID:19144517] [10.1016/j.bmcl.2008.12.097]
3. Bouchut A, Rotili D, Pierrot C, Valente S, Lafitte S, Schultz J, Hoglund U, Mazzone R, Lucidi A, Fabrizi G, Pechalrieu D, Arimondo PB, Skinner-Adams TS, Chua MJ, Andrews KT, Mai A, Khalife J..  (2019)  Identification of novel quinazoline derivatives as potent antiplasmodial agents.,  161  [PMID:30366254] [10.1016/j.ejmech.2018.10.041]
4. Huang M, Huang J, Zheng Y, Sun Q..  (2019)  Histone acetyltransferase inhibitors: An overview in synthesis, structure-activity relationship and molecular mechanism.,  178  [PMID:31195169] [10.1016/j.ejmech.2019.05.078]

Source